1.Comparative study of left bundle branch pacing in cardiac synchronization treatment system
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2024;26(6):637-641
Objective To evaluate the clinical value of left bundle branch pacing(LBBP)in HF pa-tients requiring cardiac resynchronization therapy(CRT).Methods A total of 128 HF patients who met the indicatons for CRT Class Ⅰ and Ⅱ and admitted in Department of Cardiology of Northern Jiangsu People's Hospital from January 2018 to January 2023 were consecutively recrui-ted,and 32 patients of them having left bundle branch electrode implantation due to failure of cor-onary sinus electrode implantation were assigned into the LBBP group,and the rest 96 patients getting conventional biventricular pacing(BVP)into the BVP group.The pacing parameters and other indicators were observed in the two groups at the time of implantation.Follow-up visits were made to the Special Clinic of"Arrhythmia and Cardiac Pacemaker"in Northern Jiangsu People's Hospital at 1,3,6,and 12 months after surgery,and then,the visits were conducted every 3 to 4 months thereafter.Clinical evaluation,12-lead electrocardiography,echocardiography,detections for programmable controller and pacemaker function and other tests were completed at each follow-up.Readmission or death events due to HF were recorded.Results Compared with the preoperative results,both groups obtained shorter QRS duration,better NYHA class,smaller LVEDD and increased LVEF at the last follow-up(P<0.05).At the time point,shorter QRS du-ration,better NYHA class and higher LVEF were observed in the LBBP group than the BVP group(P<0.05).There were no significant differences in pacing parameters between the two groups at the time of implantation and the last follow-up(P>0.05).No statistical difference was found in readmission rate between the LBBP group and the BVP group(18.75%vs 16.67%,P>0.05).Conclusion LBBP is safe and effective,and can improve the cardiac function of HF pa-tients.LBBP may provide a new option for patients who have failed traditional CRT.
2.Predictive value of coronary computed tomography-derived fractional flow reserve for coronary artery disease
Tianjian DU ; Xiang GU ; Ye ZHU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2024;26(9):988-992
Objective To explore the predictive value of the fractional flow reserve derived from coronary computed tomography(FFRCT)in CAD.Methods Clinical data of 136 patients(309 ma-jor coronary vessels)with suspected CAD consecutively attending to Northern Jiangsu People's Hospital from January 2020 to February 2022 were collected and retrospectively analyzed.Coro-nary computed tomography angiography(CCTA)and coronary angiography(CAG)data and FFRCT were collected.The accuracy,positive predictive value,negative predictive value,sensitivity and specificity of CCTA and FFRCT for the diagnosis of stenosis in 309 major coronary arteries were compared;the correlation between FFRCT and CAG was analyzed using the consistency test.Imaging parameters of 156 vessels were analyzed by senior radiologists for smallest luminal diam-eter,stenotic plaque length,stenotic diameter rate,stenotic area rate,stenotic lumen area and plaque properties.The 98 vessels with ≥50%coronary stenosis were assigned into the coronary group,and the 58 vessels with<50%ischaemic stenosis were into the non-coronary group.Logistic regression was used to analyze the relationship between the vessel parameters of 156 ves-sels and coronary heart disease(CHD);ROC curve was plotted to analyze the value of each pa-rameter and their combination for the diagnosis of CHD.Results The diagnostic efficacy of FFRCT was more accurate than that of CCTA for CAD(P<0.01),and the Kappa agreement anal-ysis showed that the Kappa value of the diagnostic results of FFRCT and CAG was 0.620,indica-ting high agreement(P<0.01).Lower smallest luminal diameter,lower FFRCT,longer stenotic plaque length,and higher diameter stenosis rate and area stenosis rate were observed in the coro-nary group than the non-coronary group(P<0.01).Multivariate logistic regression analysis showed that smallest luminal diameter(OR=0.536,95%CI:0.335-0.858),stenotic plaque length(OR=1.109,95%CI:1.054-1.166),and FFRCT≤0.80(OR=0.204,95%CI:0.078-0.532)were independent influencing factors in predicting CAD(P<0.01).ROC curve analysis revealed that the AUC value of combined smallest luminal diameter,stenotic plaque length,and FFRCT 0.80 together in diagnosis of CAD was 0.853(0.795-0.918).Conclusion FFRCT has a higher di-agnostic value for CAD than CCTA,and the combined diagnosis of FFRCT≤0.80,smallest luminal diameter,and stenotic plaque length can further improve the accuracy of the diagnosis of CAD.
3.Clinical characteristics and risk factors of patients with chronic heart failure and ischemic stroke
Qingyang ZHANG ; Ye ZHU ; Xiang GU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2024;26(9):1026-1030
Objective To investigate the clinical features and related risk factors of chronic heart failure(CHF)patients with ischemic stroke.Methods A total of 153 elderly CHF patients with-out atrial fibrillation(AF)/atrial flutter(AFL)admitted in our hospital from January 2021 to January 2023 were enrolled,and according to diagnosis,they were divided into CHF group(84 cases)and ischemic stroke group(69 cases,CHF+ischemic stroke).General information,medical history and auxiliary examination indicators were collected.All of them were followed up for 6 months.SPSS statistical software was used to analyze the data of the 2 groups of patients,and the risk factors related to ischemic stroke were identified.Results Significant differences were observed in terms of age,hypertension,diabetes,partial thromboplastin time,left atrial diameter,left ventricular ejection fraction,right ventricular diameter,left ventri-cular end-systolic diameter,left ventricular end-diastolic diameter,CHF classification,thrombosis risk(CHA2DS2-VASc)score,HAS-BLED score,and usage of antiplatelet agents between the two groups(P<0.05,P<0.01).Multivariate logistic regression analysis showed that CHA2DS2-VASc score(OR=2.471,95%CI:1.356-4.502,P=0.003)and HAS-BLED score(OR=6.626,95%CI:2.049-21.432,P=0.002)were independent risk factors for ischemic stroke.ROC curve analysis indicated that the AUC value of CHA2DS2-VASc score and HAS-BLED score in predicting ischemic stroke in elderly CHF patients without AF/AFL was 0.936(95%CI:0.898-0.975,P<0.01)and 0.922(95%CI:0.880-0.964,P<0.01),respectively.Conclusion High CHA2DS2-VASc score and high HAS-BLED score are independent risk factors for ischemic stroke in elderly CHF patients with-out AF/AFL.
4.Safety and efficacy of left atrial appendage occlusion for prevention of stroke in elderly patients with NVAF complicated with heart failure
Jiacai ZHAN ; Xiang GU ; Ye ZHU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2024;26(9):1031-1034
Objective To investigate the safety and efficacy of percutaneous left atrial appendage closure(LAAC)in the prevention of stroke in elderly patients with non-valvular atrial fibrillation(NVAF)complicated with heart failure(HF).Methods A total of 125 NVAF patients aged ≥65 years undergoing percutaneous LAAC in Northern Jiangsu People's Hospital from January 2019 to October 2022 were recruited,and were divided into HF group(35 patients)and non-HF(90 patients)according to whether being complicated with HF.Their clinical features,characteristics of left atrial appendage,operation procedure and follow-up results were analyzed and compared between the two groups.Results The non-HF group had significant smaller proportions of smok-ing,drinking and previous stroke,lower left ventricular ejection fraction(LVEF),and higher ratio of one-stop surgery,but lower renal dysfunction ratio and B-type natriuretic peptide(BNP)lever when compared with the HF group(P<0.05,P<0.01).There were no statistical differences in the type of occluder,shape and depth of LAA and long diameter of LAA opening,residual shunt,pericardial effusion,incidence of newly stroke onset and death ratio between the two groups dur-ing perioperative period(P>0.05).The HF group had an obviously shorter follow-up time(12.10±1.30 months vs 12.72±1.10 months,P=0.025)and higher incidence of recurrent HF(8.57%vs 0%,P=0.005)than the non-HF group.Conclusion LAAO is safe and feasible for elderly NVAF patients complicated with HF,and it is safe and effective in preventing ischemic stroke.
5.Value of metoprolol combined with Wenxin Keli in treatment of atrial tachycardia after catheter ablation due to atrial fibrillation
Huiyang GU ; Xiang GU ; Ye ZHU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2024;26(3):245-249
Objective To explore the therapeutic value of metoprolol combined with Wenxin Keli(a Chinese patent drug)on atrial tachycardia(AT)after catheter ablation in patients with atrial fibrillation(AF).Methods A total of 290 patients who were diagnosed with AF and underwent catheter ablation successfully in the Department of Cardiovascular Medicine of Northern Jiangsu People's Hospital from May 2018 to January 2022 were enrolled,and were randomly divided into Wenxin Granule group(Group W),metoprolol group(Group M),combined group(Group MW)and blank control group(Group C).The times of AT,heart beats during the longest AT episode,average heart rate and adverse reactions were compared among the 4 groups.Results The mean heart rate,episodes of AT,heart beats during the longest AT episode,and numbers of premature atrial contractions(PAC)of class Ⅰ,Ⅱ and Ⅲ in Group C in 1 year after operation were all sig-nificantly higher than the baseline levels(P<0.01),so were in the Group W,Group M and Group MW(P<0.01).Group MW had obviously lower mean heart rate,episodes of AT,heart beats dur-ing the longest AT episode,and numbers of PAC of class Ⅰ,Ⅱ and Ⅲ when compared with Group W and Group M(P<0.05).There was no significant difference in the total incidence of ad-verse reactions in Group W,Group M and Group MW(7.1%vs 13.9%vs 8.9%,P=0.301).Con-clusion Metoprolol combined with Wenxin Keli can be used to treat AT after AF catheter abla-tion.The combination can effectively reduce the average heart rate,episodes of AT,numbers of PAC and heart beats during the longest AT episode,and thus decrease the recurrence of postopera-tive AF with high safety.
6.Efficacy of dronedarone combined with metoprolol on elderlv patients with atrial arrhythmia
Yaoyao HU ; Jia LIU ; Xiang GU ; Ye ZHU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2024;26(3):258-261
Objective To investigate the efficacy of dronedarone combined with low dose metoprol-ol in the treatment of atrial tachycardia.Methods A total of 175 elderly patients with atrial tachy-cardia admitted in Northern Jiangsu People's Hospital during January 2020 to January 2022 were enrolled and then randomly divided into dronedarone group(n=57),metoprolol group(n=55)and combined group(dronedarone+metoprolol,n=48).The frequency,duration and symptom changes of arrhythmia were compared before and after treatment.Results After 3 and 6 months of administration,the total effective rate was significantly higher in the combination group than the dronedarone group and the metoprolol group(P<0.05).The frequency of atrial fibrillation(AF)attacks[(2.31±1.78)/48 h vs(11.56±18.68)/48 h],AF duration[(4.86±6.73)h/48 h vs(10.92±9.61)h/48 h],atrial flutter(AFL)attacks[(2.33±1.53)/48 h vs(4.33±1.53)/48 h]and AFL duration[(5.15±4.87)h/48 h vs(21.54±20.08)h/48 h]in the combined group,and AFL duration[(2.75±1.94)h/48 h vs(10.29±8.04)h/48 h]in the dronedarone group were reduced after 6 months of treatment(P<0.05).Conclusion In the treatment of atrial tachycardia,dronedarone combined with low dose metoprolol can not only obviously improve symptoms,but also significantly reduce the atrial premature and atrial tachycardia attacks,decrease the number and duration of AF and AFL attacks,and control heart rate effectively.
7.Value of precision management after cardiac resynchronization therapy
Jiashan CHEN ; Xiang GU ; Ye ZHU
Chinese Journal of Geriatric Heart Brain and Vessel Diseases 2024;26(3):271-275
Objective To investigate the effect of precision management on improving the symp-toms and response rate of patients after cardiac resynchronization therapy(CRT).Methods A to-tal of 97 patients with heart failure(HF)who received CRT for the first time in Department of Cardiology,Northern Jiangsu People's Hospital from January 1,2020 to December 31,2021 were enrolled in this study.They were divided into control group(53 cases)and precision management group(44 cases).CRT response rate and incidence of HF readmission or death were compared be-tween the two groups.Results The precision management group had significantly larger propor-tion of total response in 12 months after CRT than the control group(P<0.05).Kaplan-Meier survival analysis showed that the survival rate without clinical concern was obviously higher in the precision management group than the control group(P=0.018).Multivariate Cox regression analysis indicated that no precision management after surgery(HR=0.21,95%CI:0.09-0.47,P=0.005)and hospitalization for HF within 1 year before surgery(HR=3.94,95%CI:1.70-9.14,P=0.005)were the main predictors of clinical events of concern after CRT.Conclusion Postoperative precision management of CRT can increase the CRT response rate,reduce the risk of readmission or death due to HF,and improve the prognosis effectively.
8.Advances in pharmacological effects of jujuboside B.
Xiao-Na DONG ; Meng-Ting LI ; Hui-Yang GU ; Ye ZHU ; Xiang GU
China Journal of Chinese Materia Medica 2023;48(16):4295-4301
Ziziphi Spinosae Semen(ZSS) is an edible TCM derived from the dried ripe seeds of Ziziphus jujube Mill. var. spinosa(Bunge)Hu ex H. F. Chou(Rhamnaceae), which has the effects of nourishing the heart, tonifying the liver, calming the heart, tranquilizing the mind, arresting sweating, and promoting fluid production, and is widely used in the treatment and health care of diseases related to cardiovascular, nervous, and immune systems. Jujuboside B(JuB), one of the main active ingredients of ZSS, possesses various pharmacological effects with application values. This paper reviewed the chemical structure and pharmacological effects of JuB. JuB has sedative, hypnotic, antitumor, anti-platelet, anti-inflammatory, and other biological activities, which shows the potential thera-peutic effects on insomnia, tumors, coronary artery disease, airway inflammation, and liver injury. However, there are some limitations to the results of current studies. More comprehensive studies, including basic research and clinical trials, need to be carried out to provide more reliable evidence.
Humans
;
Drugs, Chinese Herbal/pharmacology*
;
Saponins/pharmacology*
;
Hypnotics and Sedatives
;
Sleep Initiation and Maintenance Disorders
;
Ziziphus/chemistry*
9.Preparation of mesoporous silica nanoparticles with different sizes and study on the correlation between size and toxicity
Xiao-wei XIE ; Meng-ying CHENG ; Wei-xiang FANG ; Xue LIN ; Wen-ting GU ; Kai-ling YU ; Ting-xian YE ; Wei-yi CHENG ; Li HE ; Hang-sheng ZHENG ; Ying-hui WEI ; Ji-gang PIAO ; Fan-zhu LI
Acta Pharmaceutica Sinica 2023;58(8):2512-2521
To investigate the crucial role of particle size in the biological effects of nanoparticles, a series of mesoporous silica nanoparticles (MSNs) were prepared with particle size gradients (50, 100, 150, 200 nm) with the traditional Stober method and adjusting the type and ratio of the silica source. The correlation between toxicity and size-caused biological effects were then further examined both
10.Expert consensus on the prevention and treatment of adverse reactions in subcutaneous immunotherapy(2023, Chongqing).
Yu Cheng YANG ; Yang SHEN ; Xiang Dong WANG ; Yan JIANG ; Qian Hui QIU ; Jian LI ; Shao Qing YU ; Xia KE ; Feng LIU ; Yuan Teng XU ; Hong Fei LOU ; Hong Tian WANG ; Guo Dong YU ; Rui XU ; Juan MENG ; Cui Da MENG ; Na SUN ; Jian Jun CHEN ; Ming ZENG ; Zhi Hai XIE ; Yue Qi SUN ; Jun TANG ; Ke Qing ZHAO ; Wei Tian ZHANG ; Zhao Hui SHI ; Cheng Li XU ; Yan Li YANG ; Mei Ping LU ; Hui Ping YE ; Xin WEI ; Bin SUN ; Yun Fang AN ; Ya Nan SUN ; Yu Rong GU ; Tian Hong ZHANG ; Luo BA ; Qin Tai YANG ; Jing YE ; Yu XU ; Hua Bin LI
Chinese Journal of Otorhinolaryngology Head and Neck Surgery 2023;58(7):643-656

Result Analysis
Print
Save
E-mail